8 records, the earliest from 25 Sep 2026. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
8 shown, page 1 of 1.
| Date | Category | Subject |
|---|---|---|
| 3 Oct 2026 | Others | Transgene Biotek Ltd - 526139 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| 3 Oct 2026 | Others | Transgene Biotek Ltd - 526139 - Compliance-57 (4) : Prior intimation to the beginning of the quarter |
| 3 Oct 2026 | Others | Transgene Biotek Ltd - 526139 - Compliance-57 (5) : intimation after the end of quarter |
| 3 Oct 2026 | Company Update | Transgene Biotek Ltd - 526139 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| 3 Oct 2026 | Company Update | Transgene Biotek Ltd - 526139 - Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015. |
| 3 Oct 2026 | Company Update | Transgene Biotek Ltd - 526139 - Reg. 32(1) Statement Of Deviation & Variation. |
| 2 Oct 2026 | Board Meeting | Transgene Biotek Ltd - 526139 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 |
| 25 Sep 2026 | Company Update | Transgene Biotek Ltd - 526139 - Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, We Wish To Inform You That The Company Has Received Approval From The Registrar Of Companies (ROC), Hyderabad, Telangana, For Extension Of Time For Holding The 36Th Annual General Meeting (AGM) Of The Company For The Financial Year Ended March 31, 2026. |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
